Nuance | GenomeWeb

Nuance

Nuance's CLU solution, which includes natural language processing capabilities that are tailored to the healthcare space, will "supplement" Watson's more general NLP abilities.

"What we're going to need to fully take advantage of Watson is to have the genetic and epigenetic information of patients so that the Watson program will be able to utilize and organize that also in medical decision making," said a researcher involved with IBM's efforts to develop an artificial intelligence system that can help doctors diagnose patients accurately and quickly.

The firms will combine technology that IBM developed for Watson, including deep question answering, natural language processing, and machine learning capabilities, with Nuance's speech recognition and Clinical Language Understanding solutions to help physicians diagnose and treat patients.

The partners will combine their respective technologies in an effort to provide hospitals, physicians, and payers access to critical and timely information with a potential role in personalized medicine.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.